Caris Life Sciences

CAI

Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. The company is headquartered in Irving, Texas and currently employs 1,846 full-time employees. The company went IPO on 2025-06-18. The firm develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

How is Caris Life Sciences (CAI) performing?

Caris Life Sciences (CAI) is up 0.0% today, trading at $34.26 with a daily range of $33.73 to $36.06. Over the past year, Caris Life Sciences hit a 52-week high of $36.06 and a low of $33.73, and is up 0.0% year-to-date.

What is the market cap of Caris Life Sciences (CAI)?

Caris Life Sciences (CAI) has a market cap of -. To see how CAI compares to other stocks, check out CoinGecko's list of stocks ranked by market cap.

Who are the different issuers of tokenized Caris Life Sciences (CAI)?

Ondo Finance is the only issuer of tokenized Caris Life Sciences on CoinGecko. Their token, CAION, has a market cap of -.

Where can I buy tokenized Caris Life Sciences (CAI)?

Tokenized Caris Life Sciences (CAI) is currently not available to trade on any exchanges listed on CoinGecko. Check back later — information will be updated when trading activity resumes.